<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbvie-ema-submission-subcutaneous-skyrizi-crohns-disease</loc>
    <lastmod>2026-08-28T22:46:05+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>AbbVie Files EMA Bid for Subcutaneous SKYRIZI in Crohn’s</news:title>
      <news:keywords>AbbVie</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/c2860d9a-ab07-413d-9952-f9866713cd64.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-cder-withdrawn-product-specific-guidances-august-2026</loc>
    <lastmod>2026-08-28T22:49:02+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Updates Withdrawn Product-Specific Guidance List</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/198c2d33-0443-4379-925c-44cf11c5198a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cdt-equity-validates-enhanced-solid-form-properties-ai-crystal-structure</loc>
    <lastmod>2026-08-28T22:47:42+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>CDT Equity Validates AI-Driven Crystal Structures for Drugs</news:title>
      <news:keywords>CDT</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/f5124592-2106-400e-8e3f-105b30cfca1a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/b-braun-medical-recalls-sodium-chloride-injection-zinc-oxide-particulate</loc>
    <lastmod>2026-08-28T22:50:26+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>B. Braun Recalls Sodium Chloride Lots Over Zinc Oxide</news:title>
      <news:keywords>B. Braun</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/bf5e692c-ec4d-4235-bc7c-79d1690d2cbc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/teva-acquires-bioxcel-dexmedetomidine-sublingual-film-bankruptcy-court-bid</loc>
    <lastmod>2026-08-28T22:44:33+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Teva Bids $125M for BioXcel’s IGALMI in Bankruptcy Sale</news:title>
      <news:keywords>Teva</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml-eu.globenewswire.com/Resource/Download/68cd1f4d-02f6-4b28-8723-30ad8605f8b5</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/celularity-musecell-innovations-us-manufacturing-collaboration-dezawa-musecell</loc>
    <lastmod>2026-08-28T11:37:40+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Celularity Signs U.S. Deal with MuseCell for Dezawa Cells</news:title>
      <news:keywords>Celularity</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://s.w.org/images/core/emoji/17.0.2/72x72/2122.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-warns-compounders-dietary-supplement-glutathione-injectable-adverse-events</loc>
    <lastmod>2026-08-28T11:39:48+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Warns Compounders on Glutathione After 30 Adverse Events</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0874ea77-dd7c-4243-b0f8-8fd9ad152269/1f591490-b0d1-49cb-a8d7-2b7e13cb3b3e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-extends-use-dates-hospira-baxter-injectable-lots-drug-shortages</loc>
    <lastmod>2026-08-28T11:41:41+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Extends Use Dates on Hospira, Baxter Vials Amid Shortages</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0874ea77-dd7c-4243-b0f8-8fd9ad152269/f1208e94-f058-4e32-ab46-4981ac2e32dd.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sanofi-vaccines-canada-fda-supplemental-approval-daptacel-dtap</loc>
    <lastmod>2026-08-28T11:37:57+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Sanofi Vaccines Wins FDA Nod for DAPTACEL DTaP Biologics License</news:title>
      <news:keywords>Sanofi</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0874ea77-dd7c-4243-b0f8-8fd9ad152269/8afa982d-dea2-4028-918d-7f5410bbb241.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/roivant-fda-approval-brepocitinib-lisraya-dermatomyositis</loc>
    <lastmod>2026-08-28T11:37:46+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Roivant Wins a First FDA Nod for Brepocitinib in Dermatomyositis</news:title>
      <news:keywords>Roivant</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/Resource/Download/c822a26b-5df5-41c7-9018-13a195ea1f51</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/priovant-fda-approval-brepocitinib-lisraya-dermatomyositis</loc>
    <lastmod>2026-08-28T11:37:58+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Priovant Wins a First FDA Nod for Brepocitinib in Dermatomyositis</news:title>
      <news:keywords>Priovant</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/Resource/Download/4c9c8a80-2004-4328-82df-68a3d9e233f1</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cronus-pharma-fda-approved-generic-robenacoxib-injection-veterinary</loc>
    <lastmod>2026-08-27T21:55:26+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Cronus Pharma Wins FDA Nod for Generic Robenacoxib Injection</news:title>
      <news:keywords>Cronus</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/e1816447-701a-4a89-b876-ba65c6313cbe.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/propanc-biopharma-prp-preclinical-pdac-tumor-growth-inhibition</loc>
    <lastmod>2026-08-27T22:07:10+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Propanc Reports Over 90% Tumor Inhibition for PRP</news:title>
      <news:keywords>Propanc</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/a2d48b7a-a99d-4f3e-990b-8af21728309b.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/verrica-pharmaceuticals-cove-2-enrollment-complete-ycanth-common-warts-phase-3</loc>
    <lastmod>2026-08-27T21:50:10+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Verrica Completes COVE-2 Enrollment for YCANTH</news:title>
      <news:keywords>Verrica</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/722fa2d3-9375-4ff9-b323-cbae2fd73544.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbott-gains-ce-mark-amulet-360-laa-occluder-atrial-fibrillation</loc>
    <lastmod>2026-08-27T21:54:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Abbott Wins CE Mark for Amulet 360 LAA Occluder</news:title>
      <news:keywords>Abbott</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cormica-compounding-enforcement-roadmap-503a-503b-inspection-deficiencies</loc>
    <lastmod>2026-08-27T22:01:06+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Cormica Publishes FDA Compounding Enforcement Roadmap</news:title>
      <news:keywords>Cormica</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/08/pharmaceutical-cleanroom-image.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sanofi-fda-updated-approval-tenivac-td-vaccine-august-2026</loc>
    <lastmod>2026-08-27T21:57:04+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Sanofi Gains Updated FDA Approval for TENIVAC Vaccine</news:title>
      <news:keywords>Sanofi</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/24fe4e02-fbb6-4f64-b1a2-5f1095b4d548.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/moleculin-miracle-trial-phase-2-3-aml-enrollment-milestone</loc>
    <lastmod>2026-08-27T22:05:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Moleculin Hits Enrollment Milestone in Relapsed AML Trial</news:title>
      <news:keywords>Moleculin</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/ac46bc10-b3d5-4fa0-8a7a-a4f8cc0ed0d7.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/nicox-secures-april-2027-pdufa-date-ncx-470-glaucoma-nda</loc>
    <lastmod>2026-08-27T14:12:46+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Nicox Secures April 2027 PDUFA Date for NCX 470 Glaucoma Drug NDA</news:title>
      <news:keywords>Nicox</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/89f67468-876a-4ab4-acdc-7d3679a793db/8b7e0483-56a0-414c-b549-cf109f43c89c.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbvie-ema-submission-risankizumab-subcutaneous-induction-crohns-disease</loc>
    <lastmod>2026-08-27T14:09:54+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>AbbVie Submit EMA Application for Risankizumab in Crohn’s Disease</news:title>
      <news:keywords>AbbVie</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/89f67468-876a-4ab4-acdc-7d3679a793db/bb884e2e-78b5-412c-a5bc-5a7d975c3898.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/revolution-medicines-fda-approval-daraxonrasib-metastatic-pancreatic-adenocarcinoma</loc>
    <lastmod>2026-08-27T14:09:58+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Revolution Medicines Wins FDA Approval for Daraxonrasib in mPDAC</news:title>
      <news:keywords>Revolution Medicines</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e05d6b50-0a18-4510-b500-c4b2cf08f0ac/aed6f2ac-fbf1-459e-b9df-9f130270dda1.png</image:loc>
    </image:image>
  </url>
</urlset>